SLIL Biomedical Corporation

Nil

Contact Details: P.O. Box 6531 Monona Wisconsin 53716-6531 United States of America Tel: (608) 819-1126 Fax: Email: slil@slil.com WWW: www.slil.com/

Loading...

Recent Publications by SLIL Biomedical Corporation:
Long-chain polyamines (oligoamines) exhibit strong cytotoxicities against human prostate cancer cells. alpha N,(omega)N-bis(ethyl) octamine SL-11160, decamine SL-11159,...	13th November, 2004	SLIL Biomedical Corp., 535 Science Drive, Suite C, Madison, WI 53711, USA.	Bioorg Med Chem. 2003 Sep 1;11(18):4121-31.
Macrocyclic polyamines deplete cellular ATP levels and inhibit cell growth in human prostate cancer cells. In solid tumors, when O(2) partial pressure drops below 10 mmHg, ATP...	6th April, 2004	SLIL Biomedical Corp., 535 Science Dr., Suite C, Madison, Wisconsin	J Med Chem. 2004 Feb 12;47(4):1051-9. DOI Direct Link
Cyclopropane-containing polyamine analogues are efficient growth inhibitors of a human prostate tumor xenograft in nude mice. Polyamine analogues 7, 10, 18, 27, and 32 containing cyclopropane rings...	13th November, 2003	SLIL Biomedical Corporation, 535 Science Drive, Suite C, Madison, WI	J Med Chem. 2003 Oct 9;46(21):4586-600. DOI Direct Link
HIV insertions within and proximal to host cell genes are a common finding in tissues containing high levels of HIV DNA and macrophage-associated p24 antigen expression. HIV integration within host cell genomic DNA is a requisite step of the...	2nd August, 2003	SLIL Biomedical Corporation, Menlo Park, California, USA.	J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):308-20.
A novel polyamine analog (SL-11093) inhibits growth of human prostate tumor xenografts in nude mice. PURPOSE: We tested the polyamine analog SL-11093...	30th July, 2003	SLIL Biomedical Corporation, Suite C, 535 Science Dr, Madison, WI	Cancer Chemother Pharmacol. 2003 Jun;51(6):488-92. Epub 2003 Apr 15. DOI Direct Link
→View more SLIL Biomedical Corporation research publications.

BioNews Results for SLIL Biomedical Corporation:
Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment	PR Newswire:  Nov 23 2009 12:43AM Matching: biomedical
UA in talks with Phoenix to build $140M center on downtown campus	San Francisco Business Times:  Nov 22 2009 12:21PM Matching: biomedical
Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seas	Stock Junction:  Nov 21 2009 7:07AM Matching: biomedical
Drug Studied As Possible Treatment For Spinal Injuries	MediLexicon:  Nov 21 2009 1:44PM Matching: biomedical
FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets	Bionity.com:  Nov 21 2009 5:27AM Matching: biomedical
Promote your company here: BioNewsCast - Press Release Distribution	→View more SLIL Biomedical Corporation news.

SLIL Biomedical Corporation Patents:
US Patent No.	Title
6809176	Quinones as disease therapies
6794545	Conformationally restricted polyamine analogs as disease therapies
6649587	Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
6482943	Quinones as disease therapies

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 250 times since April 2007, the link to the organisation's website has been followed 66 times

Search for more companies in Monona

Search for more companies in Wisconsin

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for SLIL Biomedical Corporation